查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
耶爾森氏菌診斷市場 - 增長、未來展望、競爭分析，2023-2031 年
市場調查報告書
商品編碼
1260074

耶爾森氏菌診斷市場 - 增長、未來展望、競爭分析，2023-2031 年

Yersinia Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

耶爾森氏菌是一種革蘭氏陽性細菌，可引起末端迴腸炎、腸炎、急性腹瀉、腸系膜淋巴結炎和敗血症。 耶爾森氏菌是引起胃腸炎和鼠疫的細菌，在兒童中更常見，男性比女性更常見。 此外，據說北美、北歐和斯堪的納維亞半島的鼠疫和耶爾森氏菌的流行率很高，使這些地區成為耶爾森氏菌診斷的最大市場。 此外，越來越多地採用和認識新的分子診斷工具也有助於這些市場主導地位。 另一方面，鑑於亞洲新興國家的大量未開發機會以及日本耶爾森氏菌感染的高流行率，亞太地區的耶爾森氏菌診斷市場潛力巨大。

氨基糖甘類、頭孢菌素類、四環素類、甲氧芐氨嘧啶-磺胺甲噁唑 (TMP-SMZ) 和氟奎諾酮類等藥物用於治療耶爾森氏菌感染。 診斷方法包括 ELISA、試管凝集、放射免疫測定、超聲、糞便培養、CT 掃描和結腸鏡檢查。 或者，可以通過對 16S rRNA 基因進行測序來對小腸結腸炎耶爾森菌分離株進行明確檢測。 血清學鑑定也可以通過用胞漿菌編碼的耶爾森氏菌蛋白進行免疫印跡來進行。 然而，開發適用於直接和間接診斷的更靈敏、高效和方便的快速診斷系統仍然是該市場的挑戰。

本報告中回答的關鍵問題

影響耶爾森氏菌診斷市場增長的關鍵微觀和宏觀環境因素有哪些？

現在和預測期內，產品細分和地區的主要投資領域是什麼？

到 2031 年的估計和市場預測

在預測期內，哪些細分市場的複合年增長率最快？

哪個細分市場的市場份額更大，為什麼？

低收入和中等收入國家是否在投資耶爾森氏菌診斷市場？

按地區劃分，最大的耶爾森氏菌診斷市場在哪裡？

亞太、拉丁美洲、中東和非洲等新興市場的市場趨勢和動態如何？

推動耶爾森氏菌診斷市場增長的主要趨勢是什麼？

主要競爭對手及其在全球耶爾森氏菌診斷市場的影響力的關鍵戰略是什麼？

內容

第一章前言

  • 報告內容
    • 報告的目的
    • 目標受眾
    • 主要產品
  • 市場細分
  • 調查方法
    • 第一階段 - 二次調查
    • 第二階段 - 初步調查
    • 第三階段 - 專家評審
    • 先決條件
    • 採用的方法

第 2 章執行摘要

  • 市場概況：全球耶爾森氏菌診斷市場
  • 全球耶爾森氏菌診斷市場：按 2022 年測試
  • 全球耶爾森氏菌診斷市場：按技術分類，2022 年
  • 全球耶爾森氏菌診斷市場：按地區劃分，2022 年
  • 有吸引力的投資建議：按地區劃分，2022 年

第 3 章耶爾森氏菌診斷市場：競爭分析

  • 主要供應商的市場定位
  • 供應商採用的策略
  • 主要產業戰略
  • 等級分析：2022 年與 2031 年

第 4 章耶爾森氏菌診斷市場：宏觀分析和市場動態

  • 介紹
  • 2021-2031 年全球耶爾森氏菌診斷市場價值
  • 市場動態
    • 市場驅動力
    • 市場製約因素
    • 主要問題
    • 主要機會
  • 促進因素和抑制因素的影響分析
  • 蹺蹺板分析

第 5 章耶爾森氏菌診斷市場：按測試 2021-2031

  • 市場概覽
  • 增長和收益分析：2022 年與 2031 年
  • 市場細分
    • 糞便培養
    • ELISA
    • 放射免疫分析
    • 管內聚
    • CT掃描
    • 超聲檢查
    • 結腸鏡檢查

第 6 章耶爾森氏菌診斷市場：按技術分類 2021-2031

  • 市場概覽
  • 增長和收益分析：2022 年與 2031 年
  • 市場細分
    • DNA探針
    • 免疫測定
    • 單克隆抗體
    • 聚合□鏈反應
    • 其他

第 7 章北美耶爾森氏菌診斷市場 2021-2031

  • 市場概覽
  • 耶爾森氏菌診斷市場：按測試 2021-2031
  • 耶爾森氏菌診斷市場：2021-2031 年（按技術）
  • 耶爾森氏菌診斷市場：地區 2021-2031
    • 北美
      • 美國
      • 加拿大
      • 其他北美地區

第 8 章英國和歐盟耶爾森氏菌診斷市場 2021-2031

  • 市場概覽
  • 耶爾森氏菌診斷市場：按測試 2021-2031
  • 耶爾森氏菌診斷市場：2021-2031 年（按技術）
  • 耶爾森氏菌診斷市場：地區 2021-2031
    • 英國和歐盟
      • 英國
      • 德國
      • 西班牙
      • 意大利
      • 法國
      • 其他歐洲地區

第 9 章亞太耶爾森氏菌診斷市場 2021-2031

  • 市場概覽
  • 耶爾森氏菌診斷市場：按測試 2021-2031
  • 耶爾森氏菌診斷市場：2021-2031 年（按技術）
  • 耶爾森氏菌診斷市場：地區 2021-2031
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區

第 10 章拉丁美洲耶爾森氏菌診斷市場 2021-2031

  • 市場概覽
  • 耶爾森氏菌診斷市場：按測試 2021-2031
  • 耶爾森氏菌診斷市場：2021-2031 年（按技術）
  • 耶爾森氏菌診斷市場：地區 2021-2031
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地區

第 11 章中東和非洲耶爾森氏菌診斷市場 2021-2031

  • 市場概覽
  • 耶爾森氏菌診斷市場：按測試 2021-2031
  • 耶爾森氏菌診斷市場：2021-2031 年（按技術）
  • 耶爾森氏菌診斷市場：地區 2021-2031
    • 中東和非洲
      • 海灣合作委員會
      • 非洲
      • 其他中東和非洲地區

第12章公司簡介

  • Abbott Laboratories Inc.
  • Affymetrix Inc.
  • Becton Dickinson
  • Bio-Rad Laboratories
  • Danaher Corporation
  • F. Hoffmann La-Roche
  • Gen-probe
  • Hologic
  • Thermo Fisher Scientific
  • 其他公司
Product Code: 137967-01-23

Yersinia is a gram-positive bacteria causing terminal ileitis, enterocolitis, acute diarrhea, mesenteric lymphadenitis, and sepsis. Species of Yersinia cause gastroenteritis and bubonic plague and are often observed in children, and men more than women. Moreover, the prevalence of bubonic plague and yersiniosis is reportedly high in North America, North Europe, and Scandinavian counties, making these regions the largest markets for Yersinia diagnostics. Furthermore, greater adoption of novel molecular diagnostic tools and higher awareness also contribute to the dominance of these markets. On the other hand, the Asia Pacific Yersinia diagnostics market holds great potential due to the wide presence of untapped opportunities in emerging Asian countries and the significantly high prevalence of Yersinia infection in Japan.

Treatment of Yersinia infections includes drugs such as aminoglycosides, cephalosporins, tetracyclines, trimethoprim-sulfamethoxazole (TMP-SMZ), and fluoroquinolones. The diagnostic methods used include ELISA, tube agglutination, radioimmunoassay, ultrasonography, stool culture, CT scan, and colonoscopy. Definite detection of Yersinia enterocolitica isolates can also be performed through sequencing of the 16S rRNA gene. Immunoblot with plasmodial encoded Yersinia protein also enables serological identification. However, developing more sensitive, efficient, and yet simple rapid diagnostic systems that can be applied to direct and indirect diagnosis remains a challenge in this market.

Key players identified for the Yersinia Diagnostics market include but are not limited to:

Abbott Laboratories, Inc., Affymetrix, Inc., Becton Dickinson, Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann La-Roche, Gen-probe, Hologic, Thermo Fisher Scientific, and Other notable players.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Yersinia Diagnostics market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Yersinia Diagnostics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Test

Stool Culture

ELISA

Radioimmunoassay

Tube Agglutination

CT Scan

Ultrasonography

Colonoscopy

Technology

DNA Probes

Immunoassay

Monoclonal Antibodies

PCR

Others

Region Segment (2021-2031; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Yersinia Diagnostics market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Yersinia Diagnostics market?

Which is the largest regional market for Yersinia Diagnostics market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Yersinia Diagnostics market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Yersinia Diagnostics market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Yersinia Diagnostics Market
  • 2.2. Global Yersinia Diagnostics Market, By Test, 2022 (US$ Million)
  • 2.3. Global Yersinia Diagnostics Market, By Technology, 2022 (US$ Million)
  • 2.4. Global Yersinia Diagnostics Market, By Geography, 2022 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2022

3. Yersinia Diagnostics Market: Competitive Analysis

  • 3.1. Market Positioning of Key Yersinia Diagnostics Market Vendors
  • 3.2. Strategies Adopted by Yersinia Diagnostics Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Yersinia Diagnostics Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Yersinia Diagnostics Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Stool Culture
    • 5.3.2. ELISA
    • 5.3.3. Radioimmunoassay
    • 5.3.4. Tube Agglutination
    • 5.3.5. CT Scan
    • 5.3.6. Ultrasonography
    • 5.3.7. Colonoscopy

6. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. DNA Probes
    • 6.3.2. Immunoassay
    • 6.3.3. Monoclonal Antibodies
    • 6.3.4. PCR
    • 6.3.5. Others

7. North America Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 7.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 7.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 7.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 7.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 7.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

8. UK and European Union Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 8.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 8.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.4.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.5.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.6.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

9. Asia Pacific Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 9.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 9.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.4.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.5.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.6.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

10. Latin America Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 10.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 10.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 10.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 10.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 10.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

11. Middle East and Africa Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 11.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 11.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 11.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 11.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 11.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

12. Company Profile

  • 12.1. Abbott Laboratories, Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Affymetrix, Inc.
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Becton Dickinson
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Bio-Rad Laboratories
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Danaher Corporation
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. F. Hoffmann La-Roche
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Gen-probe
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Hologic
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Thermo Fisher Scientific
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Other notable players
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 2 Global Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 3 North America Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 4 North America Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 5 U.S. Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 6 U.S. Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 7 Canada Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 8 Canada Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 9 Rest of North America Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 10 Rest of North America Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 11 UK and European Union Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 12 UK and European Union Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 13 UK Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 14 UK Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 15 Germany Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 16 Germany Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 17 Spain Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 18 Spain Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 19 Italy Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 20 Italy Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 21 France Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 22 France Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 23 Rest of Europe Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 24 Rest of Europe Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 25 Asia Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 26 Asia Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 27 China Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 28 China Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 29 Japan Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 30 Japan Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 31 India Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 32 India Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 33 Australia Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 34 Australia Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 35 South Korea Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 36 South Korea Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 37 Latin America Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 38 Latin America Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 39 Brazil Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 40 Brazil Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 41 Mexico Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 42 Mexico Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 43 Rest of Latin America Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 44 Rest of Latin America Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 45 Middle East and Africa Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 46 Middle East and Africa Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 47 GCC Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 48 GCC Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 49 Africa Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 50 Africa Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Yersinia Diagnostics Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Yersinia Diagnostics Market: Quality Assurance
  • FIG. 5 Global Yersinia Diagnostics Market, By Test, 2022
  • FIG. 6 Global Yersinia Diagnostics Market, By Technology, 2022
  • FIG. 7 Global Yersinia Diagnostics Market, By Geography, 2022
  • FIG. 8 Market Geographical Opportunity Matrix - Global Yersinia Diagnostics Market, 2022
  • FIG. 9 Market Positioning of Key Yersinia Diagnostics Market Players, 2022
  • FIG. 10 Global Yersinia Diagnostics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 11 Global Yersinia Diagnostics Market, By Test, 2022 Vs 2031, %
  • FIG. 12 Global Yersinia Diagnostics Market, By Technology, 2022 Vs 2031, %
  • FIG. 13 U.S. Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 14 Canada Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 15 Rest of North America Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 16 UK Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 17 Germany Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 18 Spain Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 19 Italy Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 20 France Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 21 Rest of Europe Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 22 China Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 23 Japan Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 24 India Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 25 Australia Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 26 South Korea Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 27 Rest of Asia Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 28 Brazil Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 29 Mexico Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 30 Rest of Latin America Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 31 GCC Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 32 Africa Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 33 Rest of Middle East and Africa Yersinia Diagnostics Market (US$ Million), 2021 - 2031